1. Home
  2. FPAY vs LEXX Comparison

FPAY vs LEXX Comparison

Compare FPAY & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPAY
  • LEXX
  • Stock Information
  • Founded
  • FPAY 2003
  • LEXX 2004
  • Country
  • FPAY United States
  • LEXX Canada
  • Employees
  • FPAY N/A
  • LEXX N/A
  • Industry
  • FPAY Diversified Commercial Services
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FPAY Consumer Discretionary
  • LEXX Health Care
  • Exchange
  • FPAY Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • FPAY 46.4M
  • LEXX 39.1M
  • IPO Year
  • FPAY N/A
  • LEXX N/A
  • Fundamental
  • Price
  • FPAY $1.66
  • LEXX $1.90
  • Analyst Decision
  • FPAY Strong Buy
  • LEXX Strong Buy
  • Analyst Count
  • FPAY 2
  • LEXX 2
  • Target Price
  • FPAY $3.25
  • LEXX $11.00
  • AVG Volume (30 Days)
  • FPAY 409.0K
  • LEXX 249.7K
  • Earning Date
  • FPAY 11-14-2024
  • LEXX 01-10-2025
  • Dividend Yield
  • FPAY N/A
  • LEXX N/A
  • EPS Growth
  • FPAY N/A
  • LEXX N/A
  • EPS
  • FPAY N/A
  • LEXX N/A
  • Revenue
  • FPAY $134,563,007.00
  • LEXX $496,923.00
  • Revenue This Year
  • FPAY $25.78
  • LEXX $20.39
  • Revenue Next Year
  • FPAY $6.46
  • LEXX $113.25
  • P/E Ratio
  • FPAY N/A
  • LEXX N/A
  • Revenue Growth
  • FPAY 24.46
  • LEXX 77.63
  • 52 Week Low
  • FPAY $0.97
  • LEXX $1.36
  • 52 Week High
  • FPAY $2.37
  • LEXX $6.85
  • Technical
  • Relative Strength Index (RSI)
  • FPAY 47.07
  • LEXX 37.49
  • Support Level
  • FPAY $1.60
  • LEXX $1.62
  • Resistance Level
  • FPAY $2.37
  • LEXX $2.25
  • Average True Range (ATR)
  • FPAY 0.20
  • LEXX 0.24
  • MACD
  • FPAY -0.02
  • LEXX -0.03
  • Stochastic Oscillator
  • FPAY 24.47
  • LEXX 34.57

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: